Neurology

Effect of ibudilast on black holes

 

REPORT FROM THE ENS 2008 – Ibudilast (MN-166, AV-411), a nonselective phosphodiesterase inhibitor, may provide some degree of neuroprotection following acute MS lesion formation, according to a retrospective analysis of MRI data from the MN-166 CL-01 study (Gammans et al. Abstract 0191. J Neurol 2008;255(suppl 2): 45).
Read More

TOPICS:

PROCESS study of spinal cord stimulation: 24-month data

 

REPORT FROM THE ENS 2008The Canadian PROCESS study compared spinal cord stimulation (SCS) plus conventional medical management (CMM) to CMM alone in 100 patients with predominant neuropathic leg pain secondary to failed back surgery syndrome (Kumar et al. Pain 2007;132:179-188).
Read More

LDL targets not met with statins post-stroke

 

REPORT FROM THE ENS 2008The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial demonstrated that atorvastatin 80 mg/day was effective in secondary prevention of ischemic stroke or TIA. At 4.9-year median follow-up, the absolute risk reduction for ischemic stroke with atorvastatin versus placebo was 2.2% (adjusted HR 0.78), although more hemorrhagic strokes occurred in the active treatment group (55 vs. 33; adjusted HR 1.66) (Amarenco et al. N Engl J Med 2006;355:549-59).
Read More